BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by dateSort by citations
Year Range
to
Clear all filters

All Papers

31+ results
Field: Liver Disease Diagnosis and Treatment

Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A

Verified

Fuminaka Sugauchi, Hiromitsu Kumada, Subrat A. Acharya, Santosh Man Shrestha et al.

Journal: Journal of General Virology
Year: 2004
Citations: 143

Complete nucleotide sequences of 19 hepatitis B virus (HBV) isolates of genotype A (HBV/A) were determined and analysed along with those of 20 previously reported HBV/A isolates. Of the 19 HBV/A isolates, six including three from Japan and three from the USA clustered with the 14 HBV/A isolates from...

Health SciencesMedicineEpidemiology
Read Source

Biochemical and histopathological profiling of Wistar rat treated with Brassica napus as a supplementary feed

Verified

Kazi Md Mahmudul Hasan, Tamanna Nasrin, Md. Anwarul Haque

Journal: Food Science and Human WellnessYear: 2017Citations: 141

Metabolic changes together with cardiovascular and hepatic factors are related to the development of diseases like myocardial lipidosis, heart disease, and profound toxicity. The aim of this animal study is to determine the effects of high erucic acid containing rapeseed oil (Brassica napus L.) vari...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Verified

Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, Vincent Wai‐Sun Wong et al.

Journal: Hepatology InternationalYear: 2025Citations: 123

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused ...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease

Verified

Anna Kotronen, Lotta Joutsi‐Korhonen, Ksenia Sevastianova, Robert Bergholm et al.

Journal: Liver InternationalYear: 2010Citations: 123

BACKGROUND AND AIMS: Obesity and the metabolic syndrome are established risk factors of venous thromboembolism. As most coagulation factors are produced exclusively by the liver and non-alcoholic fatty liver disease (NAFLD) is tightly related to metabolic disorders, we aimed at studying the associat...

Health SciencesMedicineEpidemiology
Read Source

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation

Verified

Tatsuo Kanda, George Lau, Lai Wei, Mitsuhiko Moriyama et al.

Journal: Hepatology InternationalYear: 2019Citations: 112

In the direct-acting antiviral (DAA) era for hepatitis C virus (HCV) infection, sustained virological response (SVR) is very high, but close attention must be paid to the possible occurrence of hepatocellular carcinoma (HCC) and reactivation of hepatitis B virus (HBV) in patients with co-infection w...

Health SciencesMedicineHepatologyOpen Access
Read Source

Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin

Verified

G. M. Kabir Uddin, D. Shoeb, Susannah Solaiman, Richard Marley et al.

Journal: Journal of Viral HepatitisYear: 2009Citations: 110

The prevalence of hepatitis B and hepatitis C in immigrant communities is unknown. Immigrants from south Asia are common in England and elsewhere, and the burden of viral hepatitis in these communities is unknown. We aimed to determine the prevalence of viral hepatitis in immigrants from south Asia ...

Health SciencesMedicineHepatology
Read Source

Prediction of chronic liver disease patients using integrated projection based statistical feature extraction with machine learning algorithms

Verified

Ruhul Amin, Rubia Yasmin, Sabba Ruhi, Md. Habibur Rahman et al.

Journal: Informatics in Medicine UnlockedYear: 2022Citations: 108

The healthy liver plays more than 500 organic roles in the human body, while a malfunction may be dangerous or even deadly. Early diagnosis and treatment of liver disease can improve the likelihood of survival. Machine learning (ML) is a powerful tool that can assist healthcare professionals during ...

Health SciencesHealth ProfessionsHealth Information ManagementOpen Access
Read Source

Insulin resistance in development and progression of nonalcoholic fatty liver disease

Verified

Shahinul Alam, Golam Mustafa, Mahabubul Alam, Nooruddin Ahmad

Journal: World Journal of Gastrointestinal PathophysiologyYear: 2016Citations: 108

Although insulin resistance (IR) is strongly associated with nonalcoholic fatty liver disease (NAFLD), the association of IR and NAFLD is not universal and correlation between IR and severity of NAFLD is still controversial. In this review, we summarize recent evidence that partially dissociates ins...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

Verified

Xufen Zeng, Krista A Varady, Xiangdong Wang, Giovanni Targher et al.

Journal: MetabolismYear: 2024Citations: 107

Metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), has become the leading cause of chronic liver disease worldwide. Optimal dietary intervention strategies for MAFLD are not standardized. This study aimed to achieve conse...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults

Verified

Rahanuma Raihanu Kathak, Abu Hasan Sumon, Noyan Hossain Molla, Mahmudul Hasan et al.

Journal: Scientific ReportsYear: 2022Citations: 101

Dyslipidemia, a major contributor to cardiovascular diseases, is rapidly increasing in Asian countries including Bangladesh. In addition to the cardiovascular system, abnormal lipid levels are also known to cause complications in renal and hepatic systems. The data regarding dyslipidemia and its rel...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

High Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in the Sultanate of Oman: Results of the 1991 National Survey

Verified

M Asfour, A. Lambourne, Ashraf Soliman, S. Al‐Behlani et al.

Journal: Diabetic MedicineYear: 1995Citations: 101

A national survey of glucose intolerance and cardiovascular disease risk factors in Oman has demonstrated a high prevalence of diabetes (10%) and impaired glucose tolerance (IGT, 13% in females and 8% in males). Prevalence of diabetes rose with age to a maximum of over 30% in both sexes. Prevalence ...

Health SciencesMedicineEndocrinology, Diabetes and Metabolism
Read Source

Relationship between serum uric acid and hypertension: a cross-sectional study in Bangladeshi adults

Verified

Nurshad Ali, Shakil Mahmood, Farjana Islam, Shahnaz Rahman et al.

Journal: Scientific ReportsYear: 2019Citations: 97

Experimental evidence suggests a causal role of serum uric acid (SUA) in hypertension development. Currently, there are few data available on the association between SUA and hypertension; data from Bangladeshi adults are not available yet. This study evaluated the association of SUA with hypertensio...

Health SciencesMedicineNephrologyOpen Access
Read Source

Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling

Verified

Tian Lan, Shuo Jiang, Jing Zhang, Qiqing Weng et al.

Journal: HepatologyYear: 2021Citations: 95

BACKGROUND AND AIMS: NAFLD is a key component of metabolic syndrome, ranging from nonalcoholic fatty liver to NASH, and is now becoming the leading cause of cirrhosis and HCC worldwide. However, due to the complex and unclear pathophysiological mechanism, there are no specific approved agents for tr...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

Verified

Masao Omata, Tatsuo Kanda, Lai Wei, Ming‐Lung Yu et al.

Journal: Hepatology InternationalYear: 2016Citations: 95

The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on "APASL consensus statements and recommendations for management of hepatitis C" in March 2015 to revise the "APASL consensus statements and management algorithms for hepatitis C virus infection...

Health SciencesMedicineHepatologyOpen Access
Read Source

Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

Verified

Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari et al.

Journal: Hepatology InternationalYear: 2021Citations: 92

Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific region. The hepatic vein ostial stenosis and short segment thrombosis are common in some parts of Asia-Pacific region, wh...

Health SciencesMedicineHepatology
Read Source
PreviousPage 2 of 3+Next